| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.28B | +17.0% |
| R&D Expense | $3.16B | +13.1% |
| SG&A Expense | $2.68B | -14.5% |
| Operating Income | $1.11B | +160.6% |
| Interest Expense | $633.0M | +12.0% |
| Pre-tax Income | $2.32B | +124.6% |
| Income Tax | $213.0M | +217.7% |
| Net Income | $1.89B | +120.6% |
| EPS (Basic) | $0.93 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.68B | +11.2% |
| Short-term Investments | $727.0M | +605.8% |
| Accounts Receivable | $3.40B | +22.5% |
| Current Assets | $11.30B | +22.1% |
| Total Assets | $38.70B | +20.5% |
| Current Liabilities | $9.45B | +6.8% |
| Long-term Debt | $9.56B | +2.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.58B | +458.4% |
| Capital Expenditures | $223.0M | -11.5% |
| Investing Cash Flow | -$3.23B | -97.1% |
| Financing Cash Flow | -$95.0M | -733.3% |
| Free Cash Flow | $3.36B | +762.1% |
| +120.0% |
| EPS (Diluted) | $0.87 | +118.7% |
| Total Liabilities |
| $26.02B |
| +10.2% |
| Stockholders' Equity | $11.25B | +53.3% |